开发一个复制有缺陷的mopox病毒平台,用于基础和治疗研究
Jiannan Chen1,2, Liyuan Hu1, Riccardo Vernuccio3
1Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Nature communications
|December 15, 2025
概括
研究人员开发了复制缺陷的mpox病毒 (MPXV) 颗粒来研究病毒和选抗病毒药物. 他们确定了G243-1720,一种向病毒蛋白F13的强有力的抑制剂,为病毒感染提供了一种新的治疗方法.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 马普克斯病毒 (MPXV) 爆发需要研究和抗病毒开发.
- 由于MPXV的庞大基因组和高度控制设施的要求,研究MPXV是很困难的.
研究的目的:
- 开发一个研究MPXV和查抗病毒化合物的系统.
- 为了识别新的抗天花病毒药物.
主要方法:
- 使用细菌人造染色体和重组克隆进行MPXV基因组的新组装.
- 工程复制有缺陷的MPXV粒子与特定的基因删除.
- 为了病毒基因组操纵,CRISPR-Cas9和Lambda Red的重组.
- 选一个化合物库对工程MPXV粒子.
主要成果:
- 建立了一个复制缺陷的MPXV系统,回顾了病毒生命周期的关键阶段.
- 确定了G243-1720,一种强大的宽谱抗天花病毒抑制剂.
- G243-1720 抑制了细胞外包裹病毒的形成和细胞间的传播.
- G243-1720与tecovirimat共享了一种作用机制,针对蛋白质F13的二分化.
结论:
- 复制有缺陷的MPXV粒子作为病毒研究和抗病毒发现的宝贵平台.
- G243-1720是一种有前途的化合物,用于开发新型天花病毒治疗药物.
相关概念视频
Viruses with RNA Genomes
1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Investigation of Disease Outbreaks
79
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
79


